1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZFP14 CTRPv2 pan-cancer AAC 0.23 1e-10
mRNA TIA1 CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA TCERG1L CTRPv2 pan-cancer AAC 0.22 1e-10
mRNA ZNF260 CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA BSN CTRPv2 pan-cancer AAC 0.25 2e-10
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.27 2e-10
mRNA BEND5 CTRPv2 pan-cancer AAC 0.23 2e-10
mRNA FAM57B CTRPv2 pan-cancer AAC 0.25 3e-10
mRNA RSBN1 CTRPv2 pan-cancer AAC 0.23 4e-10
mRNA TMOD2 CTRPv2 pan-cancer AAC 0.25 5e-10
Download CSV